Literature DB >> 8374249

Immunological features of sporadic multinodular goiter.

J J Corrales1, A Orfao, J M Miralles, M C López-Berges, L C García, M González, M T Mories, J San Miguel.   

Abstract

The origin of sporadic multinodular goiter is still uncertain. To obtain information on a number of unexplored immunological features, the distribution and characterization of T, B, and natural killer lymphocyte subsets were studied in the peripheral blood of 15 patients with multinodular goiter; 8 patients with Graves' disease (for reference purposes with a well-characterized autoimmune disease) and 29 age- and sex-matched healthy controls, combining double-staining immunofluorescence technique with monoclonal antibodies and flow cytometry. Although in both thyroid diseases increased CD3+ HLA-DR+ activated T cells (P < 0.01) were detected, in Graves' disease this was associated with decreased numbers of CD8 cells (P < 0.05) and an increased CD4/CD8 ratio (P < 0.01). These abnormalities were absent in multinodular goiter, which displayed increased CD8+ CD57+ cytotoxic/suppressor cells (P < 0.01). There was an increase in the percentage of natural killer cells expressing CD16 and CD57 antigens in multinodular goiter but not in Graves' disease. The B-cell associated antigens CD19 and CD19+ CD5+ were significantly increased in Graves' disease (P < 0.01), while the multinodular goiter patients exhibited only an increased number of B cells coexpressing the CD5 antigen (CD19+ CD5+), which was unrelated to the titers of anti-microsomal and antithyroglobulin autoantibodies. Our results point to the presence of several abnormalities of peripheral T, B, and natural killer lymphocytes in sporadic multinodular goiter, with a distribution pattern quite different from that observed in Graves' disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374249     DOI: 10.1007/bf00208480

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  33 in total

1.  Human auto-immune thyroiditis: clinical studies.

Authors:  D DONIACH; R V HUDSON; I M ROITT
Journal:  Br Med J       Date:  1960-02-06

Review 2.  Biology and clinical relevance of human natural killer cells.

Authors:  M J Robertson; J Ritz
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

3.  Effects of subclinical hyperthyroidism on renal handling of water and electrolytes in patients with nodular goiter.

Authors:  J J Corrales; J M Tabernero; J M Miralles; M T Hernández
Journal:  Klin Wochenschr       Date:  1991-01-04

4.  A study of thyroglobulin and peroxidase activity in the thyroid tissue of patients with non-endemic non-toxic nodular goitre.

Authors:  T Mories; J M Miralles; A Reglero; S Felipe; J J Corrales; L C Garcia
Journal:  Clin Sci (Lond)       Date:  1991-04       Impact factor: 6.124

Review 5.  The role of T lymphocytes in autoimmune thyroid disease.

Authors:  A J Ahmann; K D Burman
Journal:  Endocrinol Metab Clin North Am       Date:  1987-06       Impact factor: 4.741

6.  Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease.

Authors:  N Amino; H Mori; Y Iwatani; S Asari; Y Izumiguchi; K Miyai
Journal:  J Clin Endocrinol Metab       Date:  1982-03       Impact factor: 5.958

7.  Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.

Authors:  M E Ludgate; A M McGregor; A P Weetman; S Ratanachaiyavong; J H Lazarus; R Hall; G W Middleton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

8.  Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.

Authors:  R Jansson; A Karlsson; U Forsum
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

9.  Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics.

Authors:  J F San Miguel; J M Hernández; R González-Sarmiento; M González; I Sánchez; A Orfao; M C Cañizo; A López Borrasca
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

Review 10.  What are killer cells and what do they do?

Authors:  P G Hogan; A Basten
Journal:  Blood Rev       Date:  1988-03       Impact factor: 8.250

View more
  4 in total

1.  Status of antithyroid antibodies in Bangladesh.

Authors:  M A Hasanat; M A Rumi; M N Alam; K N Hasan; M Salimullah; M A Salam; M Fariduddin; H Mahtab; A K Khan
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

2.  Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases.

Authors:  Francisco J Martinez-Orozco; Miguel Fernandez-Arquero; Jose L Vicario; Laura Lillo-Triguero; Elena Ameyugo; Rosa Peraita-Adrados
Journal:  J Clin Med Res       Date:  2022-08-27

3.  Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study.

Authors:  Francisco Javier Martinez-Orozco; Jose Luis Vicario; Clara De Andres; Miguel Fernandez-Arquero; Rosa Peraita-Adrados
Journal:  J Clin Med Res       Date:  2016-05-29

4.  Thyroidal Transcriptomic Profiles of Pathoadaptive Responses to Congenital Hypothyroidism in XB130 Knockout Mice.

Authors:  Junichi Sugihara; Aaron Wong; Hiroki Shimizu; Jinbo Zhao; Hae-Ra Cho; Yingchun Wang; Samuel Refetoff; Peter Arvan; Mingyao Liu
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.